We are live on ! Find out more
SOW

State of Wyoming Portfolio holdings

AUM $989M
1-Year Est. Return 52.24%
This Fund
S&P 500
This Quarter Est. Return
-15.07%
1 Year Est. Return
+52.24%
3 Year Est. Return
+130.83%
5 Year Est. Return
+163.43%
10 Year Est. Return
AUM
$161M
AUM Growth
-$37.5M
Cap. Flow
-$2.61M
Cap. Flow %
-1.62%
Top 10 Hldgs %
10.32%
Holding
2,269
New
458
Increased
679
Reduced
721
Closed
406

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.18M
2
AAPL icon
Apple
AAPL
+$2.53M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.4M
4
AMZN icon
Amazon
AMZN
+$1.34M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 18.59%
2 Industrials 15.21%
3 Consumer Discretionary 13.69%
4 Healthcare 11.69%
5 Financials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
2126
TAL Education Group
TAL
$6.93B
-1
Closed
TASK icon
2127
TaskUs
TASK
$651M
-9
Closed
TBBK icon
2128
The Bancorp
TBBK
$2.81B
-2,360
Closed -$67K
TCOM icon
2129
Trip.com Group
TCOM
$29.7B
-1,141
Closed -$26K
TDOC icon
2130
Teladoc Health
TDOC
$1.29B
$0 ﹤0.01%
+2
New +$85
TEVA icon
2131
Teva Pharmaceuticals
TEVA
$42.1B
-2,578
Closed -$24K
TFIN icon
2132
Triumph Financial Inc
TFIN
$1.8B
-409
Closed -$38K
TKNO icon
2133
Alpha Teknova
TKNO
$361M
-1,005
Closed -$14K
TLYS icon
2134
Tilly's
TLYS
$130M
-9,030
Closed -$85K
TME icon
2135
Tencent Music
TME
$16.2B
-5
Closed
TNET icon
2136
TriNet
TNET
$3.09B
-1,396
Closed -$137K
TNGX icon
2137
Tango Therapeutics
TNGX
$4.51B
$0 ﹤0.01%
64
+16
+33% +$97
STLN
2138
Starling Oncology, Inc. Common Stock
STLN
$628M
-967
Closed -$7K
TRDA icon
2139
Entrada Therapeutics
TRDA
$271M
-1,060
Closed -$10K
TRMB icon
2140
Trimble
TRMB
$13.6B
$0 ﹤0.01%
+3
New +$197
TRNO icon
2141
Terreno Realty
TRNO
$7.45B
-196
Closed -$15K
TRNS icon
2142
Transcat
TRNS
$850M
-462
Closed -$37K
TRUP icon
2143
Trupanion
TRUP
$1.27B
-9
Closed -$1K
TWLO icon
2144
Twilio
TWLO
$38.4B
-1
Closed
UFPT icon
2145
UFP Technologies
UFPT
$2.52B
-309
Closed -$20K
URGN icon
2146
UroGen Pharma
URGN
$2.26B
-337
Closed -$3K
UTHR icon
2147
United Therapeutics
UTHR
$22.7B
-1,771
Closed -$318K
UTMD icon
2148
Utah Medical Products
UTMD
$227M
-211
Closed -$19K
UVE icon
2149
Universal Insurance Holdings
UVE
$1.21B
-2,889
Closed -$39K
VERA icon
2150
Vera Therapeutics
VERA
$2.27B
$0 ﹤0.01%
+28
New +$489

Similar funds

State of Wyoming's Q2 2022 Portfolio in Review

As of Q2 2022, State of Wyoming held 2,269 positions worth $161M, down 19% from $199M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

State of Wyoming's Q2 2022 filing shows 458 new, 679 increased, 721 reduced and 406 closed positions. Its largest new stake was IES Holdings: 52,691 shares worth $1.59M. The largest sale was Microsoft, an estimated $3.18M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • State of Wyoming's largest Q2 2022 buy was IES Holdings: 52,691 shares worth $1.59M.
  • State of Wyoming added most to People Inc in Q2 2022, an estimated $1.71M increase.
  • State of Wyoming's biggest Q2 2022 reduction was Microsoft, cutting an estimated $3.18M.
  • State of Wyoming fully exited Amicus Therapeutics in Q2 2022, selling an estimated $365K.
  • State of Wyoming's ten largest holdings make up 10% of its $161M portfolio in Q2 2022.
  • State of Wyoming opened 458 new positions and closed 406 in Q2 2022.
  • State of Wyoming's portfolio value fell 19% quarter-over-quarter to $161M.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.